4.7 Article

Adipose Stromal Cell Contact with Endothelial Cells Results in Loss of Complementary Vasculogenic Activity Mediated by Induction of Activin A

Journal

STEM CELLS
Volume 33, Issue 10, Pages 3039-3051

Publisher

WILEY-BLACKWELL
DOI: 10.1002/stem.2074

Keywords

Adipose stem/stromal cells; Endothelial cells; Coculture; Vasculogenesis; Activin A; FLT-1; Vascular endothelial growth factor

Funding

  1. AHA Scientist Development Grant [10SDG2720016]
  2. NIH [R01 HL77688-01]
  3. VA Merit Review grants
  4. Krannert Institute of Cardiology Endowment Fund
  5. Cryptic Masons' Medical Research Foundation

Ask authors/readers for more resources

Adipose stem/stromal cells (ASCs) after isolation produce numerous angiogenic growth factors. This justifies their use to promote angiogenesis per transplantation. In parallel, local coimplantation of ASC with endothelial cells (ECs) leading to formation of functional vessels by the donor cells suggests the existence of a mechanism responsible for fine-tuning ASC paracrine activity essential for vasculogenesis. As expected, conditioned media (CM) from ASC promoted ECs survival, proliferation, migration, and vasculogenesis. In contrast, media from EC-ASC cocultures had neutral effects upon EC responses. Media from cocultures exhibited lower levels of vascular endothelial growth factor (VEGF), hepatic growth factor, angiopoietin-1, and stromal cell-derived factor-1 compared with those in ASC CM. Activin A was induced in ASC in response to EC exposure and was responsible for overall antivasculogenic activity of EC-ASC CM. Except for VEGF, activin A diminished secretion of all tested factors by ASC. Activin A mediated induction of VEGF expression in ASC, but also upregulated expression of VEGF scavenger receptor FLT-1 in EC in EC-ASC cocultures. Blocking the FLT-1 expression in EC led to an increase in VEGF concentration in CM. In vitro pre-exposure of ASC to low number of EC before subcutaneous coimplantation with EC resulted in decrease in vessel density in the implants. In vitro tests suggested that activin A was partially responsible for this diminished ASC activity. This study shows that neovessel formation is associated with induction of activin A expression in ASC; this factor, by affecting the bioactivity of both ASC and EC, directs the crosstalk between these complementary cell types to establish stable vessels.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Gastroenterology & Hepatology

Therapeutic Use of Adipose-Derived Stromal Cells in a Murine Model of Acute Pancreatitis

Alexandra M. Roch, Thomas K. Maatman, Todd G. Cook, Howard H. Wu, Stephanie Merfeld-Clauss, Dmitry O. Traktuev, Keith L. March, Nicholas J. Zyromski

JOURNAL OF GASTROINTESTINAL SURGERY (2020)

Article Medicine, General & Internal

Whole-Body Vibration Training Increases Stem/Progenitor Cell Circulation Levels and May Attenuate Inflammation

Yameena Jawed, Eleni Beli, Keith March, Anthony Kaleth, M. Terry Loghmani

MILITARY MEDICINE (2020)

Article Cell & Tissue Engineering

Arguments for a Different Regulatory Categorization and Framework for Stromal Vascular Fraction

Ricardo L. Rodriguez, Trivia Frazier, Bruce A. Bunnell, Cecilia A. Mouton, Keith L. March, Adam J. Katz, J. Peter Rubin, Ramon Llull, Jens A. Sorensen, Jeffrey M. Gimble

STEM CELLS AND DEVELOPMENT (2020)

Editorial Material Cell & Tissue Engineering

Tissue Engineering Clinical Council Roundtable Discussion: Opportunities and Challenges in Clinical Translation

J. Peter Rubin, Geoffrey C. Gurtner, Wei Liu, Keith L. March, Riitta Seppanen-Kaijansinkko, Michael J. Yaszemski, James J. Yoo

TISSUE ENGINEERING PART A (2020)

Review Medicine, General & Internal

Immune Dysregulation in HFpEF: A Target for Mesenchymal Stem/Stromal Cell Therapy

Ruxandra Sava, Carl J. Pepine, Keith L. March

JOURNAL OF CLINICAL MEDICINE (2020)

Article Medicine, Research & Experimental

Cardiac stem cell therapy among Clinics of Uncertain Regulatory Status (COURS): under-regulated, under-observed, incompletely understood

Amanda Lindeman, Carl J. Pepine, Keith L. March

JOURNAL OF TRANSLATIONAL MEDICINE (2020)

Article Cardiac & Cardiovascular Systems

Mesenchymal stem cell secretions improve donor heart function following ex vivo cold storage

Meijing Wang, Liangliang Yan, Qianzhen Li, Yang Yang, Mark Turrentine, Keith March, I-wen Wang

Summary: This study aimed to evaluate the effectiveness of MSC-conditioned medium (CM) and extracellular vesicles (EVs) in improving ischemia/reperfusion-induced myocardial damage in donor hearts. The results showed that MSC-CM and MSC-EVs can provide better myocardial preservation during prolonged cold static storage in donor hearts. Additionally, MSC-EVs can be used for intercellular transport of miRNAs in heart transplantation.

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2022)

Article Cell Biology

Distinct Factors Secreted by Adipose Stromal Cells Protect the Endothelium From Barrier Dysfunction and Apoptosis

Hongyan Lu, Stephanie Merfeld-Clauss, Yameena Jawed, Keith L. March, Michael E. Coleman, Natalia V. Bogatcheva

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)

Article Cardiac & Cardiovascular Systems

A Phase II study of autologous mesenchymal stromal cells and c-kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT-HF trial

Roberto Bolli, Raul D. Mitrani, Joshua M. Hare, Carl J. Pepine, Emerson C. Perin, James T. Willerson, Jay H. Traverse, Timothy D. Henry, Phillip C. Yang, Michael P. Murphy, Keith L. March, Ivonne H. Schulman, Sohail Ikram, David P. Lee, Connor O'Brien, Joao A. Lima, Mohammad R. Ostovaneh, Bharath Ambale-Venkatesh, Gregory Lewis, Aisha Khan, Ketty Bacallao, Krystalenia Valasaki, Bangon Longsomboon, Adrian P. Gee, Sara Richman, Doris A. Taylor, Dejian Lai, Shelly L. Sayre, Judy Bettencourt, RachelW. Vojvodic, Michelle L. Cohen, Lara Simpson, David Aguilar, Catalin Loghin, Lem Moye, Ray F. Ebert, Barry R. Davis, Robert D. Simari

Summary: The CONCERT-HF trial demonstrated the safety and feasibility of CPCs and MSCs treatment in ischemic cardiomyopathy-induced heart failure patients, with CPCs reducing MACE and MSCs improving quality of life. Further investigation is warranted to explore the potential beneficial effects of these cell types in heart failure.

EUROPEAN JOURNAL OF HEART FAILURE (2021)

Article Cardiac & Cardiovascular Systems

Bone marrow- or adipose-mesenchymal stromal cell secretome preserves myocardial transcriptome profile and ameliorates cardiac damage following ex vivo cold storage

Susan R. Scott, Keith L. March, I-Wen Wang, Kanhaiya Singh, Jianyun Liu, Mark Turrentine, Chandan K. Sen, Meijing Wang

Summary: The study showed that using MSC secretome (particularly from bone marrow MSCs and adipose-MSCs) during prolonged cold storage preserves the normal transcriptional fingerprint, improves myocardial function depression, reduces inflammatory cytokine production, decreases apoptosis, and reduces myocardial damage, suggesting the synergistic protective effects of MSC-released soluble factors and exosomes on donor hearts.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2022)

Article Oncology

Newly diagnosed cardiovascular disease in patients treated with immune checkpoint inhibitors: a retrospective analysis of patients at an academic tertiary care center

Nida Waheed, Michael G. Fradley, David L. DeRemer, Ahmad Mahmoud, Chintan P. Shah, Taimour Y. Langaee, Gloria P. Lipori, Keith March, Carl J. Pepine, Rhonda M. Cooper-DeHoff, Yonghui Wu, Yan Gong

Summary: This study indicates a high incidence of newly diagnosed cardiovascular disease after initiation of ICI therapy in a real-world clinical setting. Most incidents of cardiovascular disease were diagnosed shortly after initial exposure to ICIs, with some patients experiencing cardiotoxic effects leading to higher mortality rates.

CARDIO-ONCOLOGY (2021)

Article Biochemical Research Methods

A multiplexed ion-exchange membrane-based miRNA (MIX•miR) detection platform for rapid diagnosis of myocardial infarction

Xiang Ren, Bradley W. Ellis, George Ronan, Stuart Ryan Blood, Cameron DeShetler, Satyajyoti Senapati, Keith L. March, Eileen Handberg, David Anderson, Carl Pepine, Hsueh-Chia Chang, Pinar Zorlutuna

Summary: The research has developed a miRNA detection platform for rapid diagnosis of acute myocardial infarction, which can increase detection sensitivity and reduce detection time. The expression levels of miR-1 show significant differences among different types of cardiac patients, helping to differentiate between various heart conditions.

LAB ON A CHIP (2021)

Article Cell & Tissue Engineering

Adipose stem cell secretome markedly improves rodent heart and human-induced pluripotent stem cell-derived cardiomyocyte recovery from cardioplegic transport solution exposure

Bradley W. Ellis, Dmitry O. Traktuev, Stephanie Merfeld-Clauss, Uryan Isik Can, Meijing Wang, Ray Bergeron, Pinar Zorlutuna, Keith L. March

Summary: Heart transplantation is a life-saving therapy for end-stage organ failure, but organ deterioration during transportation limits the number of hearts available for transplantation. Studies show that adipose-derived stem/stromal cell secretome (ASC-S) can ameliorate organ damage and increase the pool of hearts acceptable for transplantation.

STEM CELLS (2021)

Article Oncology

Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients The CCTRN SENECA Trial

Roberto Bolli, Emerson C. Perin, James T. Willerson, Phillip C. Yang, Jay H. Traverse, Timothy D. Henry, Carl J. Pepine, Raul D. Mitrani, Joshua M. Hare, Michael P. Murphy, Keith L. March, Sohail Ikram, David P. Lee, Connor O'Brien, Jean-Bernard Durand, Kathy Miller, Joao A. Lima, Mohammad R. Ostovaneh, Bharath Ambale-Venkatesh, Adrian P. Gee, Sara Richman, Doris A. Taylor, Shelly L. Sayre, Judy Bettencourt, Rachel W. Vojvodic, Michelle L. Cohen, Lara M. Simpson, Dejian Lai, David Aguilar, Catalin Loghin, Lem Moye, Ray F. Ebert, Barry R. Davis, Robert D. Simari

JACC: CARDIOONCOLOGY (2020)

No Data Available